These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
176 related articles for article (PubMed ID: 21744292)
1. Treatment of acute heart failure using levosimendan for a patient with dilated cardiomyopathy, chronic renal failure, and hypertension. Lobo Martínez P; Oulego Erroz I; Gautreux Minaya S; Rodríguez Fernández LM Pediatr Cardiol; 2011 Oct; 32(7):1012-6. PubMed ID: 21744292 [TBL] [Abstract][Full Text] [Related]
2. [Levosimendan treatment of severe acute congestive heart failure refractory to dobutamine/milrinone in children]. Prijić S; Rakić S; Nikolić L; Jovicić B; Stajević M; Vukomanović V; Kosutić J Vojnosanit Pregl; 2011 Nov; 68(11):979-84. PubMed ID: 22191317 [TBL] [Abstract][Full Text] [Related]
3. Levosimendan. A promising future drug for refractory cardiac failure in children? Kushwah S; Kumar A; Sahana KS Indian Heart J; 2016 Apr; 68 Suppl 1(Suppl 1):S57-60. PubMed ID: 27056655 [TBL] [Abstract][Full Text] [Related]
4. Patients with advanced heart failure and the effects of levosimendan. Song ZZ; Ma J Am J Cardiol; 2007 Aug; 100(4):742; author reply 742-3. PubMed ID: 17697841 [No Abstract] [Full Text] [Related]
5. Can we believe in levosimendan? Follath F Arq Bras Cardiol; 2008 Mar; 90(3):146-7. PubMed ID: 18392391 [No Abstract] [Full Text] [Related]
6. Levosimendan vs. dobutamine: outcomes for acute heart failure patients on beta-blockers in SURVIVE. Mebazaa A; Nieminen MS; Filippatos GS; Cleland JG; Salon JE; Thakkar R; Padley RJ; Huang B; Cohen-Solal A Eur J Heart Fail; 2009 Mar; 11(3):304-11. PubMed ID: 19158152 [TBL] [Abstract][Full Text] [Related]
8. Levosimendan in patients with low-output heart failure: lessons from the LIDO trial. Follath F Ital Heart J; 2003 May; 4 Suppl 2():34S-38S. PubMed ID: 14635368 [TBL] [Abstract][Full Text] [Related]
9. Novel biologic mechanisms of levosimendan and its effect on the failing heart. Parissis JT; Andreadou I; Bistola V; Paraskevaidis I; Filippatos G; Kremastinos DT Expert Opin Investig Drugs; 2008 Aug; 17(8):1143-50. PubMed ID: 18616411 [TBL] [Abstract][Full Text] [Related]
10. Efficacy of levosimendan in patients with chronic heart failure: Does rhythm matter? Yontar OC; Yilmaz MB; Yalta K; Tandoğan I Anadolu Kardiyol Derg; 2010 Aug; 10(4):310-6. PubMed ID: 20693125 [TBL] [Abstract][Full Text] [Related]
11. Effects of levosimendan versus dobutamine on left atrial function in decompensated heart failure. Duman D; Palit F; Simsek E; Bilgehan K; Sacide A Can J Cardiol; 2009 Oct; 25(10):e353-6. PubMed ID: 19812809 [TBL] [Abstract][Full Text] [Related]
12. [Levosimendan in heart failure]. Scelsi L; Campana C; Ghio S; Monti L; Opasich C; De Feo S; Cobelli F; Orlandi M; Di Pasquale G; Tavazzi L Recenti Prog Med; 2004; 95(7-8):376-83. PubMed ID: 15303549 [TBL] [Abstract][Full Text] [Related]
13. The predictive value of QRS duration in response to levosimendan therapy in patients with decompensated heart failure. Cetin M; Uçar O; Cicekçioğlu H; Güven Cetin Z; Sahin M; Vasfi Ulusoy F; Aydoğdu S Acta Cardiol; 2012 Jun; 67(3):317-23. PubMed ID: 22870740 [TBL] [Abstract][Full Text] [Related]
14. Effects of levosimendan versus dobutamine on inflammatory and apoptotic pathways in acutely decompensated chronic heart failure. Adamopoulos S; Parissis JT; Iliodromitis EK; Paraskevaidis I; Tsiapras D; Farmakis D; Karatzas D; Gheorghiade M; Filippatos GS; Kremastinos DT Am J Cardiol; 2006 Jul; 98(1):102-6. PubMed ID: 16784930 [TBL] [Abstract][Full Text] [Related]
15. The Hemodynamic Effects and Safety of Repetitive Levosimendan Infusions on Children With Dilated Cardiomyopathy. Suominen P; Mattila N; Nyblom O; Rautiainen P; Turanlahti M; Rahkonen O World J Pediatr Congenit Heart Surg; 2017 Jan; 8(1):25-31. PubMed ID: 28033083 [TBL] [Abstract][Full Text] [Related]
16. Effect of levosimendan on ventricular arrhythmias and prognostic autonomic indexes in patients with decompensated advanced heart failure secondary to ischemic or dilated cardiomyopathy. Flevari P; Parissis JT; Leftheriotis D; Panou F; Kourea K; Kremastinos DT Am J Cardiol; 2006 Dec; 98(12):1641-5. PubMed ID: 17145226 [TBL] [Abstract][Full Text] [Related]
17. Levosimendan use in several scenarios of acute heart failure. Tavares M; Andrade AC; Mebazaa A Arq Bras Cardiol; 2008 Mar; 90(3):211-5. PubMed ID: 18392402 [TBL] [Abstract][Full Text] [Related]
18. Comparative effects of levosimendan and dobutamine on right ventricular function in patients with biventricular heart failure. Yilmaz MB; Yontar C; Erdem A; Karadas F; Yalta K; Turgut OO; Yilmaz A; Tandogan I Heart Vessels; 2009 Jan; 24(1):16-21. PubMed ID: 19165563 [TBL] [Abstract][Full Text] [Related]
19. Acute effects of levosimendan on mitral regurgitation and diastolic function in patients with advanced chronic heart failure. Branzi G; Malfatto G; Villani A; Ciambellotti F; Revera M; Giglio A; Rosa FD; Facchini M; Parati G J Cardiovasc Med (Hagerstown); 2010 Sep; 11(9):662-8. PubMed ID: 20613551 [TBL] [Abstract][Full Text] [Related]
20. Early levosimendan administration may improve outcome in patients with subarachnoid hemorrhage complicated by acute heart failure. Papanikolaou J; Tsolaki V; Makris D; Zakynthinos E Int J Cardiol; 2014 Oct; 176(3):1435-7. PubMed ID: 25147072 [No Abstract] [Full Text] [Related] [Next] [New Search]